Nemours, UD technology pushes cancer research forward

20:00 EDT 9 Aug 2017 | AAAS

(Nemours) Nemours Biomedical Research and the University of Delaware (UD) Department of Materials Science and Engineering have developed a patent-pending process to make 3-D models work in high throughput screening labs, allowing drug discovery to move into more meaningful screening systems. Sigrid Langhans, PhD, of Nemours, along with Darrin Pochan, PhD, of UD and colleagues, published an article about their findings this week in Analytical Biochemistry.

Original Article: Nemours, UD technology pushes cancer research forward


More From BioPortfolio on "Nemours, UD technology pushes cancer research forward"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...